研究单位：[1]Shanghai Zhongshan Hospital[2]Xijing Hospital[3]Changhai Hospital[4]Eastern Hepatobiliary Surgery Hospital[5]Shanghai Cancer Hospital, China[6]Shengjing Hospital[7]The Third Affiliated Hospital of Harbin Medical University[8]Jilin Provincial Tumor Hospital[9]Zhejiang Cancer Hospital[10]Jiangsu Cancer Institute & Hospital[11]Guangdong Provincial People's Hospital[12]Sichuan Cancer Hospital and Research Institute[13]Henan Cancer Hospital[14]Anhui Provincial Hospital[15]The First Affiliated Hospital of Anhui Medical University[16]Qilu Hospital of Shandong University[17]Shandong Tumor Hospital[18]First Affiliated Hospital of Xinjiang Medical University[19]Chinese PLA General Hospital[20]Nanfang Hospital of Southern Medical University[21]Wuhan Union Hospital, China[22]LanZhou University[23]Sun Yat-sen University[24]Hunan Provincial People's Hospital[25]The Affiliated Zhongshan Hospital of Dalian University
It is a prospective and multi-center clinical research in China to compare the efficacy, safety and related impact factors between TACE alone and TACE combined with synchronous multi-point MWA/RFA for large and huge liver cancer.
